Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | May 22, 2026 | May 26, 2026 |
| PFIZER INCPFE · Entity 2863 | Group President | February 28, 2020 | March 03, 2020 |
| Viatris IncVTRS · Entity 3277 | Director · Chief Executive Officer | March 02, 2023 | March 07, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date May 22, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 76,020 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 45,871 · Balance 76,020 F1: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.
PFIZER INC
Report date February 28, 2020 · Filed March 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,812 |
Ending reported balance
After 2020-02-28 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-02-28 · Exercise / conversion · Acquired 22,852 · Balance 53,036 F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Row 2 · 2020-02-28 · Tax withholding · Disposed 4,419 · Balance 48,617 F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Row 3 · 2020-02-28 · Tax withholding · Disposed 11,805 · Balance 36,812 F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $27.37 · Expires 2020-02-28 | Direct | 0 |
Reported balance
After 2020-02-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-02-28 · Exercise / conversion · Disposed 22,852 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Viatris Inc
Report date March 02, 2023 · Filed March 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,653 |
Ending reported balance
After 2023-03-04 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2023-03-02 · Exercise / conversion · Acquired 84,908 · Balance 294,432 Row 2 · 2023-03-02 · Tax withholding · Disposed 37,173 · Balance 257,259 F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021. Row 3 · 2023-03-02 · Exercise / conversion · Acquired 6,715 · Balance 263,974 F2: Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Row 4 · 2023-03-02 · Tax withholding · Disposed 2,940 · Balance 261,034 F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Row 5 · 2023-03-04 · Exercise / conversion · Acquired 104,085 · Balance 365,119 Row 6 · 2023-03-04 · Tax withholding · Disposed 45,569 · Balance 319,550 F4: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022. Row 7 · 2023-03-04 · Exercise / conversion · Acquired 3,742 · Balance 323,292 F5: Fractional shares have been rounded up in connection with the settlement described in footnote 12 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Row 8 · 2023-03-04 · Tax withholding · Disposed 1,639 · Balance 321,653 F6: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 84,908 |
Reported balance
After 2023-03-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-03-02 · Exercise / conversion · Disposed 84,908 · Balance 84,908 F7: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 84,908 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023. Mr. Goettler is separating from Viatris on April 1, 2023 and, as a result, the 84,908 RSUs granted on March 2, 2021 that would have vested on March 2, 2024 will be forfeited upon his separation. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 208,170 |
Reported balance
After 2023-03-04 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-03-04 · Exercise / conversion · Disposed 104,085 · Balance 208,170 F10: Each RSU represents the right to receive one share of common stock of Viatris. 104,085 of the RSUs granted on March 4, 2022 vested on March 4, 2023. Mr. Goettler is separating from Viatris on April 1, 2023 and, as a result, the 104,085 RSUs granted on March 4, 2022 that would have vested on each of March 4, 2024 and March 4, 2025, in each case, will be forfeited upon his separation. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,714 |
Reported balance
After 2023-03-02 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-03-02 · Exercise / conversion · Disposed 6,714.7382 · Balance 6,714 F8: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F9: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,483 |
Reported balance
After 2023-03-04 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2023-03-04 · Exercise / conversion · Disposed 3,741.5173 · Balance 7,483 F11: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F12: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021.
F2: Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021.
F4: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022.
F5: Fractional shares have been rounded up in connection with the settlement described in footnote 12 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F6: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022.
F7: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 84,908 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023. Mr. Goettler is separating from Viatris on April 1, 2023 and, as a result, the 84,908 RSUs granted on March 2, 2021 that would have vested on March 2, 2024 will be forfeited upon his separation.
F8: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.
F9: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.
F10: Each RSU represents the right to receive one share of common stock of Viatris. 104,085 of the RSUs granted on March 4, 2022 vested on March 4, 2023. Mr. Goettler is separating from Viatris on April 1, 2023 and, as a result, the 104,085 RSUs granted on March 4, 2022 that would have vested on each of March 4, 2024 and March 4, 2025, in each case, will be forfeited upon his separation.
F11: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.
F12: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2021 Filed Feb 24, 2021 23:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 3,499 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008068 · doc4.xml · derivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on February 22, 2021. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on February 22, 2021. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 23:01 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 1,522 | $15.50 | $23,591.00 |
DisclosureSEC source: 0000899243-21-008068 · doc4.xml · nonDerivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,081 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the restricted stock units (RSUs) granted on November 20, 2020. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 23:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 3,499 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008068 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:10 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 119,975 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032088 · doc4.xml · derivative · entry 4 GOETTLER MICHAEL · CIK 0001745691 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,975 Underlying: Common Stock · 119,975 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 27, 2023. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 27, 2023. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:10 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 53,958 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032088 · doc4.xml · derivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,958 Underlying: Common Stock · 53,958 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 28, 2022. F3 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 28, 2022. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:10 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 3,499 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-032088 · doc4.xml · derivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,499 Underlying: Common Stock · 3,499 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 22, 2021. F2 · derivative.expiration_date: Each restricted stock unit ("RSU") represents the right to receive one share of common stock of Viatris. The RSUs will vest on February 22, 2021. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 22,852 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-20-004022 · doc4.xml · derivative · entry 4 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,852 shares Expires 2020-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 11,805 | $36.45 | $430,292.25 |
DisclosureSEC source: 0001225208-20-004022 · doc4.xml · nonDerivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,812 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,419 | $33.42 | $147,682.98 |
DisclosureSEC source: 0001225208-20-004022 · doc4.xml · nonDerivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,617 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 17:54 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 22,852 | $27.37 | $625,459.24 |
DisclosureSEC source: 0001225208-20-004022 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 20,129 | $0.00 Strike: $34.59 | $0.00 |
DisclosureSEC source: 0001225208-20-003798 · doc4.xml · derivative · entry 6 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,129 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 15,365 | $36.80 | $565,432.00 |
DisclosureSEC source: 0001225208-20-003798 · doc4.xml · nonDerivative · entry 5 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,184 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,906 | $34.72 | $66,176.32 |
DisclosureSEC source: 0001225208-20-003798 · doc4.xml · nonDerivative · entry 4 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,549 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,266 | $34.72 | $43,955.52 |
DisclosureSEC source: 0001225208-20-003798 · doc4.xml · nonDerivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,455 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 3,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003798 · doc4.xml · nonDerivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:22 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 20,129 | $34.59 | $696,262.11 |
DisclosureSEC source: 0001225208-20-003798 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2020 Filed Feb 25, 2020 23:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,116 | $35.72 | $75,583.52 |
DisclosureSEC source: 0001225208-20-003502 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,428 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F2 · price: Price is the closing price of Pfizer common stock on February 21, 2020. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 60,846 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · derivative · entry 8 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,846 Underlying: Common Stock · 60,846 shares Expires 2026-02-28 F8 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F8 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 72,201 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · derivative · entry 7 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,201 Underlying: Common Stock · 72,201 shares Expires 2024-02-28 F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 30,017 | $0.00 Strike: $32.23 | $0.00 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · derivative · entry 6 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,017 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 18,538 | $42.31 | $784,342.78 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · nonDerivative · entry 5 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,249 F5 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F6 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,989 | $42.93 | $257,107.77 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · nonDerivative · entry 4 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,787 F4 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,556 | $42.93 | $152,659.08 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · nonDerivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,776 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 6,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · nonDerivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,332 F2 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 30,017 | $32.23 | $967,447.91 |
DisclosureSEC source: 0001225208-19-004211 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 00:11 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,788 | $43.08 | $77,027.04 |
DisclosureSEC source: 0001225208-19-003775 · doc4.xml · nonDerivative · entry 4 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,635 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:11 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 19,290 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-19-003775 · doc4.xml · derivative · entry 5 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,290 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:11 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,007 | $41.91 | $251,753.37 |
DisclosureSEC source: 0001225208-19-003775 · doc4.xml · nonDerivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,423 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:11 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,077 | $42.96 | $218,107.92 |
DisclosureSEC source: 0001225208-19-003775 · doc4.xml · nonDerivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,430 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 22, 2019 Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 00:11 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 19,290 | $21.03 | $405,668.70 |
DisclosureSEC source: 0001225208-19-003775 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:38 UTC | PFIZER INC PFE · Entity 2863 | OtherPhantom Stock Units · Derivative | 17,383 | $40.27 | $700,013.41 |
DisclosureSEC source: 0001225208-18-012256 · doc4.xml · derivative · entry 5 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,383 Underlying: Common Stock · 17,383 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: The units, held under the Deferred Compensation Plan are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: The units, held under the Deferred Compensation Plan are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:38 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 10,958 | $39.69 | $434,923.02 |
DisclosureSEC source: 0001225208-18-012256 · doc4.xml · nonDerivative · entry 4 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,924 Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:38 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,340 | $39.71 | $132,631.40 |
DisclosureSEC source: 0001225208-18-012256 · doc4.xml · nonDerivative · entry 3 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,882 Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:38 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,300 | $39.70 | $131,010.00 |
DisclosureSEC source: 0001225208-18-012256 · doc4.xml · nonDerivative · entry 2 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,222 Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:38 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,600 | $39.72 | $63,552.00 |
DisclosureSEC source: 0001225208-18-012256 · doc4.xml · nonDerivative · entry 1 GOETTLER MICHAEL · CIK 0001745691 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,522 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.